Denis Fourches, Joseph Pilotte, Brian E Watts, Daniel J Saltzberg, Robert M Cicchillo
{"title":"Targeted Protein Degradation for Agricultural Applications: Rationale, Challenges, and Outlook.","authors":"Denis Fourches, Joseph Pilotte, Brian E Watts, Daniel J Saltzberg, Robert M Cicchillo","doi":"10.1021/acsbiomedchemau.5c00111","DOIUrl":null,"url":null,"abstract":"<p><p>Farmers urgently need novel technologies to ensure global food security for the rapidly expanding population, yet crop protection has seen little innovation in decades. Mounting regulatory pressures, pest resistance, and environmental concerns are driving demand for novel sustainable solutions. Beyond traditional small molecule active ingredients, very few alternative modalities (<i>e.g</i>., peptides, RNAi, biopesticides) have reached the market. Meanwhile, targeted protein degradation (TPD) has emerged as a breakthrough modality for human therapeutics, with numerous proteolysis-targeting chimeras (PROTACs) and molecular glues (MGs) advancing through clinical trials. Those compounds induce potent and selective degradation of protein targets via the ubiquitin-proteasome system (UPS). Recently, PROTACs have been shown to function in both insect cells and in whole insect organisms, marking a pivotal step toward their use as next-generation crop protection solutions. In this perspective, we showcase the rationale, key challenges, and potential breadth of applications of targeted protein degraders for agricultural purposes. The TPD technology is a promising and potentially disruptive alternative to traditional small molecule inhibitors in agriculture.</p>","PeriodicalId":29802,"journal":{"name":"ACS Bio & Med Chem Au","volume":"5 5","pages":"778-791"},"PeriodicalIF":3.5000,"publicationDate":"2025-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12531867/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Bio & Med Chem Au","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1021/acsbiomedchemau.5c00111","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/10/15 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Farmers urgently need novel technologies to ensure global food security for the rapidly expanding population, yet crop protection has seen little innovation in decades. Mounting regulatory pressures, pest resistance, and environmental concerns are driving demand for novel sustainable solutions. Beyond traditional small molecule active ingredients, very few alternative modalities (e.g., peptides, RNAi, biopesticides) have reached the market. Meanwhile, targeted protein degradation (TPD) has emerged as a breakthrough modality for human therapeutics, with numerous proteolysis-targeting chimeras (PROTACs) and molecular glues (MGs) advancing through clinical trials. Those compounds induce potent and selective degradation of protein targets via the ubiquitin-proteasome system (UPS). Recently, PROTACs have been shown to function in both insect cells and in whole insect organisms, marking a pivotal step toward their use as next-generation crop protection solutions. In this perspective, we showcase the rationale, key challenges, and potential breadth of applications of targeted protein degraders for agricultural purposes. The TPD technology is a promising and potentially disruptive alternative to traditional small molecule inhibitors in agriculture.
期刊介绍:
ACS Bio & Med Chem Au is a broad scope open access journal which publishes short letters comprehensive articles reviews and perspectives in all aspects of biological and medicinal chemistry. Studies providing fundamental insights or describing novel syntheses as well as clinical or other applications-based work are welcomed.This broad scope includes experimental and theoretical studies on the chemical physical mechanistic and/or structural basis of biological or cell function in all domains of life. It encompasses the fields of chemical biology synthetic biology disease biology cell biology agriculture and food natural products research nucleic acid biology neuroscience structural biology and biophysics.The journal publishes studies that pertain to a broad range of medicinal chemistry including compound design and optimization biological evaluation molecular mechanistic understanding of drug delivery and drug delivery systems imaging agents and pharmacology and translational science of both small and large bioactive molecules. Novel computational cheminformatics and structural studies for the identification (or structure-activity relationship analysis) of bioactive molecules ligands and their targets are also welcome. The journal will consider computational studies applying established computational methods but only in combination with novel and original experimental data (e.g. in cases where new compounds have been designed and tested).Also included in the scope of the journal are articles relating to infectious diseases research on pathogens host-pathogen interactions therapeutics diagnostics vaccines drug-delivery systems and other biomedical technology development pertaining to infectious diseases.